Financial report interval: 2024.12.31 - 2025.12.31
Overview: JW THERAP-B(02126) the Revenue is 315.43 M (+87.4%), Beat estimate;the EBIT is -275.93 M (+44.36%), Beat estimate;the EPS is -1.49 (+2.05%), Miss estimate.